Sphingosine and Its Analog, the Immunosuppressant 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, Interact with the CB1 Cannabinoid Receptor

  title={Sphingosine and Its Analog, the Immunosuppressant 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, Interact with the CB1 Cannabinoid Receptor},
  author={Steven W. Paugh and Michael P. Cassidy and Hengjun He and Sheldon Milstien and L. J. Sim-Selley and Sarah Spiegel and Dana E Selley},
  journal={Molecular Pharmacology},
  pages={41 - 50}
Sphingosine-1-phosphate (S1P) and cannabinoid receptors are G-protein-coupled receptors that mediate the effects of S1P and endocannabinoids, respectively. Cannabinoid receptors also mediate the effects of Δ9-tetrahydrocannabinol, the primary psychoactive ingredient in marijuana, whereas S1P receptors contribute to the immunosuppressant effects of 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol (FTY720). FTY720 is a sphingosine analog that can prevent renal graft rejections and suppress a… 

Figures and Tables from this paper

Endocannabinoids and Their Pharmacological Actions.

  • R. Pertwee
  • Biology, Chemistry
    Handbook of experimental pharmacology
  • 2015
Current in vitro data indicate the extent to which some established or putative orthosteric endocannabinoids seem to target non-cannabinoid receptors and ion channels, particularly at concentrations at which they have been found to interact with CB(1) or CB(2) receptors.

Sphingosine‐1‐phosphate receptors mediate neuromodulatory functions in the CNS

It is reported that S1P stimulated G‐protein activity in the CNS, and results from [35S]GTPγS autoradiography show that in several regions a majority of this activity is mediated by S 1P1 receptors, indicating that CNS S1 P receptors are part of a physiologically relevant and widespread neuromodulatory system.

FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells*

The data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids.

Advances in Neurobiology and Pharmacology of GPR12

This review analyzes all the direct available information in PubMed database about expression, function, and pharmacology of this receptor in central nervous system (CNS) trying to provide a broad overview of its current and prospective neurophysiology.

The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts

A dose-dependent effect of mAEA on ΔΨm, mediated by TRPV1, was evidenced; in particular, low doses were responsible for increased ΔΩm, whereas a high dose negatively modulated Δάm and cell survival.

Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.

Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis

Data herein identify CBD and THC as TLR3 and TLR4 modulating drugs in primary immune cells in vitro, and offers insight on the cellular target(s) of phytocannabinoids in targeting inflammation in the context of MS.



Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.

Lysophospholipid Receptors in the Nervous System

Neuroscientists have recently begun to explore the role of lysophospholipid receptors in a number of cell types; this research has implicated these receptors in the survival, migration, and differentiation of cells in the mammalian nervous system.

Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells

Treatment of rat C6 glioma cells with the raft disruptor methyl-β-cyclodextrin doubles the binding efficiency of type-1 cannabinoid receptors (CB1R), and CB1R activation underlies the protective effect of MCD against apoptosis.

Ceramide: a new second messenger of cannabinoid action.

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

Overexpression of EDG-1 induced exaggerated cell-cell aggregation, enhanced expression of cadherins, and formation of well-developed adherens junctions in a manner dependent on SPP and the small guanine nucleotide binding protein Rho.

Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm.

Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors.

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

It is shown here that cannabinoid treatment induces both phosphorylation and activation of mitogen-activated protein (MAP) kinases, and that these effects are inhibited by SR 141716A, a selective CB1 antagonist.

Internalization and Recycling of the CB1 Cannabinoid Receptor

It is found that CB1 receptors are rapidly internalized following agonist binding and receptor activation, and this results show thatCB1 receptor trafficking is dynamically regulated by cannabimimetic drugs.

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

It is considered premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, because pharmacological evidence for the existence of additional types of cannabinoid receptor is emerging and other kinds of supporting evidence are still lacking.